Overview

The INFECIR-2 Albumin Prevention Study

Status:
Terminated
Trial end date:
2017-02-10
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate whether albumin administration improves short-term survival in patients with advanced cirrhosis and bacterial infections other than Spontaneous Bacterial Peritonitis (SBP).
Phase:
Phase 4
Details
Lead Sponsor:
EASL - CLIF Consortium